Inventor · disambiguated record
Gennady Nisnevich
Also filed as: NISNEVICH GENNADY · NISNEVICH GENNADY A
28 granted patents·14 pending applications·159 citations·filing 2001–2016
96Inventor score
Top patents by PatentIndex Score
42 records- 0191US7166730B2Process for the preparation of prostaglandin derivativesFINE TECH LAB LTD·Filed 2005·Granted Jan 23, 2007·26 cites·22 claims
- 0290US8383842B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolPURDUE PHARMA LP·Filed 2005·Granted Feb 26, 2013·13 cites·35 claims
- 0387US9744151B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolSVC PHARMA LP·Filed 2016·Granted Aug 29, 2017·6 cites·31 claims
- 0487US8937097B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolPURDUE PHARMA LP·Filed 2013·Granted Jan 20, 2015·7 cites·20 claims
- 0586US7227026B2Synthesis of irbesartanTEVA PHARMA·Filed 2006·Granted Jun 5, 2007·3 cites·3 claims
- 0686US7217825B2Synthesis of irbesartanTEVA PHARMA·Filed 2006·Granted May 15, 2007·3 cites·12 claims
- 0785US7157590B2Process for the preparation of 17-phenyl-18,19,20-thinor-pgf 2a and its derivativesFINETECH LAB LTD·Filed 2002·Granted Jan 2, 2007·19 cites·14 claims
- 0885US6958398B1Methods for making thebaine or its acid saltsEURO CELTIQUE SA·Filed 2003·Granted Oct 25, 2005·15 cites·49 claims
- 0984US9278083B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolSVC PHARMA LP·Filed 2015·Granted Mar 8, 2016·4 cites·18 claims
- 1083US6849737B2Synthesis and purification of valacyclovirTEVA PHARMA·Filed 2002·Granted Feb 1, 2005·12 cites·24 claims
- 1181US7019148B2Synthesis of irbesartanTEVA PHARMA·Filed 2004·Granted Mar 28, 2006·7 cites·3 claims
- 1280US6849736B2Crystalline forms of valacyclovir hydrochlorideTEVA PHARMA·Filed 2002·Granted Feb 1, 2005·11 cites·26 claims
- 1379US7947740B2Bimatoprost crystalline form IFINETECH PHARMACEUTICAL LTD·Filed 2007·Granted May 24, 2011·7 cites·27 claims
- 1478US7838683B2Synthesis of irbesartanTEVA PHARMA·Filed 2007·Granted Nov 23, 2010·1 cites·17 claims
- 1576US7332612B2Amorphous and crystalline forms of losartan potassium and process for their preparationTEVA PHARMA·Filed 2002·Granted Feb 19, 2008·8 cites·10 claims
- 1676US7038060B2Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-oneTEVA PHARMA·Filed 2004·Granted May 2, 2006·8 cites·11 claims
- 1765US7262327B2Recycling process for preparing sertralineTEVA PHARMA·Filed 2004·Granted Aug 28, 2007·3 cites·50 claims
- 1864US7301035B2Intermediates for the synthesis of irbesartanTEVA PHARMA·Filed 2006·Granted Nov 27, 2007·0 cites·1 claims
- 1964US7247730B2Process for the preparation of dexmethylphenidate hydrochlorideISP INVESTMENTS INC·Filed 2004·Granted Jul 24, 2007·4 cites·11 claims
- 2062US2008167498A1Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereofTEVA PHARMACEUTICAL USA LTD·Filed 2008·Application pending·0 cites
- 2161US2009216026A1Novel synthesis of irbesartanNISNEVICH GENNADY·Filed 2008·Application pending·0 cites
- 2260US2008096945A1Amorphous and Crystalline Forms of Losartan Potassium and Process For Their PreparationDOLITZKY BEN Z·Filed 2007·Application pending·0 cites
- 2358US9675581B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinolSVC PHARMA LP·Filed 2016·Granted Jun 13, 2017·0 cites·24 claims
- 2455US7026483B2Forms of cabergolineFINETECH LAB LTD·Filed 2004·Granted Apr 11, 2006·2 cites·14 claims
- 2554US7312340B2Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-oneTEVA PHARMA·Filed 2006·Granted Dec 25, 2007·0 cites·14 claims
- 2652US2004220278A1Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereofFiled 2004·Application pending·0 cites
- 2751US2005130993A1Synthesis and purification of valacyclovirFiled 2005·Application pending·0 cites
- 2850US9637462B2Process for the preparation of N-iodoamidesTECHNION RES & DEV FOUNDATION·Filed 2014·Granted May 2, 2017·0 cites·24 claims
- 2949US2011288179A1Bimatoprost crystalline form iGUTMAN ARIE·Filed 2011·Application pending·0 cites
- 3048US2002183553A1Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereofFiled 2001·Application pending·0 cites
- 3148US2005187229A1Crystalline forms of valacyclovir hydrochlorideFiled 2005·Application pending·0 cites
- 3242US2005043329A1Crystalline forms of valacyclovir hydrochlorideFiled 2004·Application pending·0 cites
- 3341US2005176794A1Novel synthesis of irbesartanFiled 2003·Application pending·0 cites
- 3440US2005239837A1Process for production of highly pure donepezil hydrochlorideGUTMAN ARIE L·Filed 2005·Application pending·0 cites
- 3539US2004192919A1Process for production of highly pure donepezil hydrochlorideFINETECH LAB LTD·Filed 2003·Application pending·0 cites
- 3639US2005215600A1Polymorphs of torsemide hydrochloride and process for production thereofGUTMAN ARIE·Filed 2004·Application pending·0 cites
- 3738US10399917B2Process for the preparation of organic bromidesTECHNION RES & DEV FOUNDATION·Filed 2016·Granted Sep 3, 2019·0 cites·36 claims
- 3838US8822516B2Process for the preparation of iodidesNISNEVICH GENNADY·Filed 2011·Granted Sep 2, 2014·0 cites·13 claims
- 3938US8318960B2Diarylphosphine- and dialkylphosphine-containing compounds, processes of preparing same and uses thereof as tridentate ligandsGANDELMAN MARK·Filed 2010·Granted Nov 27, 2012·0 cites·4 claims
- 4038US7002016B2Process for the preparation of threo-methylphenidate hydrochlorideISP INVESTMENTS INC·Filed 2004·Granted Feb 21, 2006·0 cites·6 claims
- 4136US10899687B2Process for the preparation of organic halidesTECHNION RES & DEV FOUNDATION·Filed 2016·Granted Jan 26, 2021·0 cites·28 claims
- 4231US2004186300A1Process for the preparation of zafirlukastFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →